epocrates logo
epocrates logo
epocrates logo
  • Home
  • Search
  • Tools
  • Saved
  • 0
    Notifications
  • CME
  • Help & Feedback
  • About Us
  • Business Solutions

The clinical information you need, at your fingertips.

Medical News for You

Journal Article Synopsis

JAMA Netw Open

1h

Is it time to rethink oral iron first in pregnancy anemia?

Meta-analysis of nearly 12,000 patients links IV iron to fewer transfusions and better maternal and neonatal iron status. . .

Journal Article Synopsis

Neurology

2h

Stroke nearly doubled in young adults, while falling in older ones

Ischemic stroke drove the rise over almost three decades in a US population study, as traditional risk factors and substance use climbed among young patients. . .
Internally Generated Content

IDSA/ESCMID

4h

Staph aureus bacteremia: New framework aims to personalize care

IDSA and ESCMID move beyond a simple “complicated” versus “uncomplicated” approach to SAB. . .
Journal Article Synopsis

Eur Heart J

5h

Only half of semaglutide heart benefit traces to known risk factors

The remainder remains unexplained, strengthening the case for semaglutide as a cardiovascular drug. . .
Journal Article Synopsis

Circulation

7h

Low FFR-CT signals higher risk after coronary CTA

Nationwide study links lower CT-derived fractional flow reserve values to increased risk of MI, cardiovascular death, and revascularization. . .

Journal Article Synopsis

Lancet Global Health

9h

Delayed appendicitis care linked to higher perforation risk

Global study suggests surgical assessment within 24 hours of symptom onset may help prevent serious complications. . .
Journal Article Synopsis

BMJ

11h

Oral menopause hormone therapy linked to clot risk even at low doses

Transdermal treatment showed no overall increase in blood clots, stroke, or heart attack. . .
Journal Article Synopsis

Drug pipeline

13h

Targeted therapy shows phase 3 benefit in rare genetic form of ALS

Investigational ulefnersen could expand treatment options for patients with an often rapidly progressive form of ALS. . .
Journal Article Synopsis

Company news

21h

FDA panel backs first multi-cancer blood test approval

Advisers found Galleri's benefits outweigh its risks for cancer screening in adults 50 and older. . .
Government Health Agency News

FDA

1d

FDA approves Aqneursa, first treatment for ataxia in ataxia-telangiectasia

Oral suspension offers children and adults an option to ease ataxia symptoms that affect mobility, speech, and daily life. . .
Trending icon

TRENDING THIS WEEK

learn more about epocrates plus

Clinical FAQs

Check out the answers to frequently asked questions about our clinical content.

About Us

Features

Business Solutions

Help & Feedback

Terms of Use

Privacy Policy

visit epocrates on instagram
visit epocrates on facebook
visit epocrates on youtube
visit epocrates on twitter
visit epocrates on linkedIn

© 2026 epocrates, Inc.

download epocrates on app storedownload epocrates on google play

Do not sell or share my personal information

Download Epocrates from the App StoreDownload Epocrates from the Play Store
About UsFeaturesBusiness SolutionsHelp & FeedbackCookie Preferences
© 2026 epocrates, Inc.   Terms of UsePrivacy PolicyEditorial PolicyDo Not Sell or Share My Information